North Star Investment Management Corp. Altimmune, Inc. Transaction History
North Star Investment Management Corp.
- $1.35 Billion
- Q2 2024
A detailed history of North Star Investment Management Corp. transactions in Altimmune, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 13,100 shares of ALT stock, worth $103,228. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,100
Previous 3,000
336.67%
Holding current value
$103,228
Previous $30,000
190.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALT
# of Institutions
191Shares Held
42.4MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$41.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$38.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$30.8 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$25.4 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$21.7 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $386M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...